Epigenetic Precision Medicine Solutions

Business

Molecular diagnostics, biomarker discovery, and pharmacoepigenomic screening

Core Technology

Epimutation signature detection using novel methods

Foundational IP Control

In the areas of DNA Methylation and transgenerational disease inheritance

Epigenetic Mechanisms and Marks

  • DNA Methylation

  • Histone Modifications

  • Chromatin Structure

  • Non-coding RNA

Summary. EpigeneSys will exploit proprietary technology and initially use contract service providers and collaborators with known clinical cohorts to identify disease associated epigenetic biomarkers and epigenetic signatures.  Subsequently, the Company will develop diagnostic products/services using more appropriate [lower cost] targeted technology and these diagnostics will be provided as a clinical service in a CLIA lab.  The Company is seeking investors and partners to execute the commercialization strategy.